Tag: Professor Dr. Paul DeAngelis
Caisson Biotech and Heparinex Announce Positive Exam Report of European Patent and the Discovery of a New Class of Sugar Polymers
eNewsChannels NEWS: -- Caisson Biotech and parent company Heparinex are pleased to announce that they have received a positive examination report from the European Patent Office for a patent covering the chemoenzymatic production of heparosan utilized in the HEPtune® drug delivery platform. Once certified, the new patent family will increase patent coverage across Europe, adding to the U.S. holdings.
